Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1400 participants
OBSERVATIONAL
2019-04-16
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Management of Metastatic Colorectal Cancer: A Clinical and Patient Perspective
NCT03935763
Urinary and Sexual Dysfunctions Evaluation After Rectal Resection
NCT04404673
Comprehensive Genomic Profiling of Colorectal Cancer Patients With Isolated Liver Metastases to Understand Response & Resistance to Cancer Therapy
NCT03364621
Evaluation of Diffusion Weighted Imaging -MRI in Patients With Resectable Liver Metastases From Colorectal Cancer
NCT02355353
Cd133+ Cell Infusion in Patients With Colorectal Liver Metastases.
NCT03803241
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The primary objective of this analysis is to assess the employed resources by National Health System related to surgical activities for primary colorectal cancer during a collaborative and systematic auditing activity in 8 Surgical Units of Emilia-Romagna. A project team composed by experts in colorectal cancer care will be created with the task of identifying the needed resources to allocate to the project and the set of administrative, economic and performance indicators to be measured during the project. A friendly, time-preserving dataset that includes all the items to be collected to measure established indicators will be developed. An analysis on costs and performance indicators will be conducted on colorectal procedures performed between 1 January 2019 and 31 December 2019 within the participating centers. From the second year auditing activity will be implemented among institutions of Emilia-Romagna. Analysis results obtained from the first year of collecting data will be used as a starting feedback report to implement the auditing activity dedicated to colorectal cancer. During the whole second year monthly feedback reports will be drafted and used for monitoring costs and performances outcomes of colorectal surgery procedures between 1 January 2020 and 31 December 2020.
At the end of the second year a final analysis will be performed to compare resources employed for colorectal cancer surgery between the first and second year. Economical and performance data will be collected.
Focusing on costs, the main sources to be used are administrative databases. Full in-hospital costs will be collected for each patient for the time interval between the day of admission for surgery and the following post-operative 90-days. The Diagnosis Related Groups (DRG) standardized payments will be used to calculate inpatient costs.
Another source for cost and performance information is the clinical chart (paper or electronic) in all its parts. The investigators will focus primarily on set of data, that potentially could contribute to define the cost of care on basis of post-operative pathway. Key performance indicators common to both colon and rectal surgery or specific for one of the two surgical procedure will be considered.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Colon surgery
patients diagnosed with colon cancer, who undergone at least one surgical procedure at one of participating hospitals during the observational period
all colorectal cancer surgical procedures
colorectal cancer surgical procedures
Rectal surgery
patients diagnosed with rectal cancer, who undergone at least one surgical procedure at one of participating hospitals during the observational period
all colorectal cancer surgical procedures
colorectal cancer surgical procedures
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
all colorectal cancer surgical procedures
colorectal cancer surgical procedures
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Underwent colorectal cancer surgery;
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mattia Altini, physician
Role: PRINCIPAL_INVESTIGATOR
IRST
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Istituto Scientifico Romagnolo per lo studio e la cura dei tumori
Meldola, FC, Italy
AUO Chirurgia Generale e D'Urgenza Ospedale M.Bufalini
Cesena, Forli-Cesena, Italy
AUO CHIRURGIA GENERALE OSPEDALE G. B. Morgagni- Pierantoni
Forlì, Forli-Cesena, Italy
Auo Chirurgia Generale Ospedale Degli Infermi
Faenza, Ravenna, Italy
AUO Chirurgia Generale Ospedale Umberto I
Lugo, Ravenna, Italy
AUO Chirurgia Generale Ospedale Ceccarini
Riccione, Rimini, Italy
AOU Chirurgia Generale Ospedale G. Da Saliceto
Piacenza, , Italy
AUO Chirurgia Generale ed Urgenza Ospedale S. Maria delle Croci
Ravenna, , Italy
Auo Chirurgia Generale Ospedale Degli Infermi
Rimini, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Massa I, Ghignone F, Ugolini G, Ercolani G, Montroni I, Capelli P, Garulli G, Catena F, Lucchi A, Ansaloni L, Gentili N, Danesi V, Montella MT, Altini M; ESCA Collaborative Group. Emilia-Romagna Surgical Colorectal Cancer Audit (ESCA): a value-based healthcare retro-prospective study to measure and improve the quality of surgical care in colorectal cancer. Int J Colorectal Dis. 2022 Jul;37(7):1727-1738. doi: 10.1007/s00384-022-04203-w. Epub 2022 Jul 2.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRST153.07
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.